How do you pay?

How to pay the least

Cash price

$1,350+ for 30 tablets

Pharmacies pay about this for Myfembree; you’d pay more.

  1. Ask your pharmacy for Myfembree’s cash price, and one or two other pharmacies too.
  2. Myfembree’s savings card works only with insurance from a job or one you bought.

No generic is sold yet.

Compare every option

Question
Brand nameMyfembree
Authorized genericrelugolix, estradiol hemihydrate, and norethindrone
Regular genericrelugolix, estradiol hemihydrate, and norethindrone
What you’d pay
At least$1,350for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Myfembree?
The original
–
–

Brand nameThe maker’s card

Myfembree Copay Assistance Program

Savings card from Sumitomo Pharma America

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $5 a prescription

The card takes up to $5,000 a year off your co-pay.

Sign up on myfembree.com 

Or call 1-833-693-3627.

In the maker’s words

“With this Copay Program, eligible patients may pay as little as $5 per prescription for up to an 84-day supply of Myfembree.”

From the maker’s offer on myfembree.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Myfembree itself, from the same company, sold without the brand name, and usually for less. For now Myfembree is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

MYFEMBREE is a combination of relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, estradiol, an estrogen, and norethindrone acetate, a progestin, indicated in premenopausal women for the:

  • management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids).
  • management of moderate to severe pain associated with endometriosis.

Limitations of Use

Use of MYFEMBREE should be limited to 24 months due to the risk of continued bone loss which may not be reversible.

Source: the FDA label for Myfembree (Sumitomo Pharma America, Inc), September 4, 2025. Full label on DailyMed 

Good to know